Clinicopathological Characteristics of Hepatocellular Carcinoma with Microscopic Portal Venous Invasion and the Role of Anatomical Liver Resection in These Cases
Author(s) -
Shimada Shingo,
Kamiyama Toshiya,
Yokoo Hideki,
Orimo Tatsuya,
Wakayama Kenji,
Einama Takahiro,
Kakisaka Tatsuhiko,
Kamachi Hirofumi,
Taketomi Akinobu
Publication year - 2017
Publication title -
world journal of surgery
Language(s) - English
Resource type - Journals
SCImago Journal Rank - 1.115
H-Index - 148
eISSN - 1432-2323
pISSN - 0364-2313
DOI - 10.1007/s00268-017-3964-0
Subject(s) - hepatocellular carcinoma , medicine , abdominal surgery , gastroenterology , vascular surgery , portal vein , surgical margin , cardiac surgery , cardiothoracic surgery , lesion , carcinoma , risk factor , vascular invasion , hepatectomy , portal venous system , pathology , resection , cancer , surgery , portal hypertension , cirrhosis
Background The aims of this study were to investigate predictive factors for microscopic portal venous invasion (mPVI) in hepatocellular carcinoma (HCC) and whether anatomical liver resection (ALR) was useful in such cases. Methods We analyzed 852 patients with HCC without macroscopic portal venous invasion who were treated at our hospital between January 1990 and May 2014. These patients were stratified into a microscopic portal venous invasion group (mPVI group; n = 153) and non‐microscopic portal venous invasion group (NmPVI group; n = 699). Results PIVKA‐II ≥100 mAU/ml, a tumor size ≥5 cm, a confluent lesion, and poor differentiation were found to be independent risk factors for mPVI. Among the mPVI group who had single HCC under 5 cm, serum albumin level <4.0 g/dl, PIVKA‐II ≥100 mAU/ml, a positive surgical margin, and non‐ALR (NALR) were independent unfavorable prognostic factors for overall survival (OS). PIVKA‐II ≥100 mAU/ml, a positive surgical margin and NALR were independent unfavorable prognostic factors for relapse‐free survival (RFS). ALR was significantly favorable factor for both OS and RFS of the mPVI group who had single HCC under 5 cm. Conclusions Even if no portal venous invasion is detectable in HCC patients preoperatively, a PIVKA‐II ≥100 mAU/ml, tumor size ≥5 cm, and a confluent lesion indicate a high risk of mPVI. ALR should be considered for the patients with these characteristics because it is a favorable prognostic factor in these cases with mPVI.
Accelerating Research
Robert Robinson Avenue,
Oxford Science Park, Oxford
OX4 4GP, United Kingdom
Address
John Eccles HouseRobert Robinson Avenue,
Oxford Science Park, Oxford
OX4 4GP, United Kingdom